Stay updated with breaking news from Leuven imcyse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
Pfizer takes equity stake in Imcyse as part of the recently announced Rheumatoid Arthritis license agreement Major existing shareholders participated in the round Proceeds to advance Imcyse’s pipeline of first-in-class targeted disease modifying immunotherapeutics Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of … Pfizer takes equity stake in Imcyse as part of the recently announced Rheumatoid Arthritis license agreement Major existing shareholders participated in the round Proceeds to advance Imcyse’s pipeline of first-in-class targeted disease modifying immunotherapeutics Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, today announced that it has concluded a Series B extension financing round, raising EUR 21.3 million ....
DGAP-News: Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder vom 17.02.2021, 14:00 Uhr Bild: pixabay.com DGAP-News: Imcyse SA / Key word(s): Financing Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder 17.02.2021 / 14:00 The issuer is solely responsible for the content of this announcement. Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder Pfizer takes equity stake in Imcyse as part of the recently announced Rheumatoid Arthritis license agreement Major existing shareholders participated in the round Proceeds to advance Imcyse s pipeline of first-in-class targeted disease modifying immunotherapeutics ....
Investegate |Imcyse SA Announcements | Imcyse SA: Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.